Prescription medicine
Albumin aggregated Brand names: Draximage, Pulmotech
Albumin aggregated (Draximage) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the albumin aggregated FDA label on DailyMed (effective October 13, 2025); every albumin aggregated label on DailyMed.
Highlights of the record
FDA label of October 13, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usagePULMOTECH MAA, after radiolabeling with technetium-99m, is indicated for: Lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients.
Forms and strengths
- 2.5 mg
- 2 mg/15ml
Injection (powder) for solution; injection (powder) (lyophilized) for suspension.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 2 of which 0 under generic applications, 2 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 1 since 2022 0 Class I among all firms' recalls; latest June 16, 2022
- FAERS reports
- 33 through July 30, 2026
What is albumin aggregated used for?
From the label: indications and usagePULMOTECH MAA, after radiolabeling with technetium-99m, is indicated for: Lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients. Peritoneovenous shunt scintigraphy as an aid in the evaluation of its patency in adults. PULMOTECH MAA, after radiolabeling with technetium-99m is a radioactive diagnostic agent indicated for: Lung scintigraphy as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients. ( 1 ) Peritoneovenous shunt scintigraphy as an aid in the evaluation of its patency in adults.
Source: FDA drug label (Pulmotech MAA), Curium US LLC, effective October 13, 2025 (SPL set a8b7adf0-2c6b-4acd-96d3-a099306951a0), via openFDA; the full label on DailyMed
Is there a generic for albumin aggregated (Draximage)?
No generic albumin aggregated is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
Has albumin aggregated been recalled?
The FDA's Enforcement Report lists 1 recall naming albumin aggregated since 2022: 0 Class I (the most serious), 1 Class II, 0 Class III; 0 still ongoing. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| June 16, 2022 | Class II | Jubilant Draximage Inc | Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing. |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What does the albumin aggregated label say about other medicines?
The albumin aggregated label names 2 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Pentetic acid | contraindications | CONTRAINDICATIONS DRAXIMAGE MAA is contraindicated in patients with: Severe pulmonary hypertension [see Warnings and Precautions (5.1)]. |
| Tetrakis copper tetrafluoroborate | warnings and precautions | Have emergency resuscitation equipment and trained personnel available prior to administration of Technetium Tc 99m Albumin Aggregated Injection. Monitor all patients for hypersensitivity reactions. |
Source: FDA drug label (Pulmotech MAA), Curium US LLC, effective October 13, 2025 (SPL set a8b7adf0-2c6b-4acd-96d3-a099306951a0), via openFDA; the full label on DailyMed
What do FAERS reports show for albumin aggregated?
The FDA Adverse Event Reporting System holds 33 reports that list albumin aggregated among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 1 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Albumin aggregated side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other